Ranjani Rajapaksa
- Immunology top 2%
- Immunotherapy and Immune Responses 11
- Immune Cell Function and Interaction 10
- T-cell and B-cell Immunology 3
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 4
- Hematology top 5%
- Acute Myeloid Leukemia Research 3
- Platelet Disorders and Treatments 3
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 3
- Genetics top 10%
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Ronald LevyShoshana LevyDebra K. CzerwinskiChiung-Chi KuoAurélien MarabelleBehnaz TaidiJohn M. TimmermanClemens B. Caspar
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Investigation (2 papers)The Journal of Experimental Medicine (1 paper)
- Partner nations
- United StatesFranceMexico
In The Last Decade
Ranjani Rajapaksa
23 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 73
- Immunology 1.3k
- Immunology and Allergy 193
- Hematology 333
- Oncology 807
- Genetics 128
Countries citing papers authored by Ranjani Rajapaksa
This map shows the geographic impact of Ranjani Rajapaksa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranjani Rajapaksa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranjani Rajapaksa more than expected).
Fields of papers citing papers by Ranjani Rajapaksa
This network shows the impact of papers produced by Ranjani Rajapaksa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranjani Rajapaksa. The network helps show where Ranjani Rajapaksa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ranjani Rajapaksa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 9 | |
| 2 | 2021 | 41 | |
| 3 | 2019 | 31 | |
| 4 | 2017 | 1 | |
| 5 | 2017 | 45 | |
| 6 | 2015 | 67 | |
| 7 | 2015 | 17 | |
| 8 | 2013 | 279 | |
| 9 | 2012 | 9 | |
| 10 | 2011 | 1 | |
| 11 | 2010 | 34 | |
| 12 | 2009 | 44 | |
| 13 | 2006 | 12 | |
| 14 | 2006 | 77 | |
| 15 | 2003 | 98 | |
| 16 | 2002 | 68 | |
| 17 | 2000 | 107 | |
| 18 | 1996 | 5 | |
| 19 | 1996 | 155 | |
| 20 | Modulation of apoptosis in human myeloid leukemic cells by GM-CSF. | 1995 | 24 |
About Ranjani Rajapaksa
Ranjani Rajapaksa is a scholar working on Immunology, Immunology and Allergy and Hematology, having authored 23 papers that have together received 1.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (10 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Cell Adhesion Molecules Research (4 papers), Acute Myeloid Leukemia Research (3 papers), Platelet Disorders and Treatments (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Immunology (1.3k citations), Immunology and Allergy (193 citations) and Hematology (333 citations). Ranjani Rajapaksa has collaborated with scholars based in United States, France and Mexico. Frequent co-authors include Ronald Levy, Shoshana Levy, Debra K. Czerwinski, Chiung-Chi Kuo, Aurélien Marabelle, Behnaz Taidi, John M. Timmerman, Clemens B. Caspar, Edgar G. Engleman and Claudia Benike. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.